A Study of ICP-033 in Patients With Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
A Dose finding Study to Evaluate the Safety, Tolerability and Pharmacokinetics and
Preliminary Anti-Tumor Activity of ICP-033 Tablets in Patients with Advanced Solid Tumors.